| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/06/2013 | CN102917721A Wnt antagonists and methods of treatment and screening |
| 02/06/2013 | CN102917713A Proangiogenic compositions, method for preparing same, and uses thereof |
| 02/06/2013 | CN102917694A Tablet formulation of ezatiostat |
| 02/06/2013 | CN102917693A Implant devices that differe by release profile and methods of making and using same |
| 02/06/2013 | CN102917691A Process for making dry and stable hemostatic compositions |
| 02/06/2013 | CN102911943A Chicken Cathelicidins antibacterial peptide and preparation method and application for same |
| 02/06/2013 | CN102911279A Polysaccharide-peptide and liposome thereof |
| 02/06/2013 | CN102911267A TB/HIV (tuberculosis/human immunodeficiency virus) antigen peptide bispecific TCR (T cell receptor) as well recombinant retroviral vector and application thereof |
| 02/06/2013 | CN102911266A Novel salmon calcitonin analogue and preparation method as well as use thereof |
| 02/06/2013 | CN102911264A Platelet aggregation inhibitor composition |
| 02/06/2013 | CN102911261A Agrocybe aegerita lectin AAL-2 and coding gene thereof, preparation method and application thereof |
| 02/06/2013 | CN102911260A Antagonists against interaction of PF4 and RANTES |
| 02/06/2013 | CN102911257A Cyclic lipopeptide antibiotic and preparation and application thereof |
| 02/06/2013 | CN102911254A HCV (hepatitis C virus) protease inhibitor |
| 02/06/2013 | CN102911251A Bicyclol-glutathione conjugate and preparation method and application thereof |
| 02/06/2013 | CN102908631A Function of actin 84 lysine monomethylation in cytokinesis and cell proliferation as well as application thereof to drug development |
| 02/06/2013 | CN102908629A Lipid-based drug of serum degradable carrier and application method of lipid-based drug |
| 02/06/2013 | CN102908627A pH-sensitive nanoparticles for oral insulin delivery |
| 02/06/2013 | CN102908614A Antioxidant health-care product containing SOD (Superoxide Dismutase) mixed with plant extract |
| 02/06/2013 | CN102908613A Porcine immuno-enhancer IL-12B (P40) and preparation method thereof |
| 02/06/2013 | CN102908612A Applications of TRAIL truncated mutant in activating NF-kappaB and in inflammatory responses |
| 02/06/2013 | CN102908611A Bioprotein dressing and bioprotein invisible film for preventing and controlling human papilloma virus infection |
| 02/06/2013 | CN102908610A Propolis combination used for livestock and preparation method of same |
| 02/06/2013 | CN102908609A Endoparasiticidal compositions |
| 02/06/2013 | CN102908608A Health care method for improving vaccine immunity effect and reducing immunity stress response of livestock and poultry |
| 02/06/2013 | CN102908364A Mesenchymal stem cell injection, as well as preparation method and application in preparing medicament for treating children dilated cardiomyopathy |
| 02/06/2013 | CN102908332A Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery |
| 02/06/2013 | CN102362856B Recombinant bovine basic fibroblast grow factor external solution |
| 02/06/2013 | CN102250214B Polypeptide for resisting rheumatoid arthritis and application of polypeptide in pharmacy |
| 02/06/2013 | CN102241748B Mycobacterium phage D29 derived PK34 polypeptide and application thereof |
| 02/06/2013 | CN102210717B Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains |
| 02/06/2013 | CN102160890B Pharmaceutical composition comprising an analgesic peptide |
| 02/06/2013 | CN102133231B Product prepared by shark cartilage for supplementing calcium and promoting metabolism and development of cartilage and preparation method thereof |
| 02/06/2013 | CN101632832B Component for reducing body fat formation and application thereof |
| 02/06/2013 | CN101584854B Romurtide cyclodextrin inclusion compound, preparation thereof and method for preparing same |
| 02/06/2013 | CN101549146B Romurtide injection and preparation method thereof |
| 02/06/2013 | CN101314775B RNA disturbance target point capable of being used for treating AIDS |
| 02/06/2013 | CN101287487B Agents and methods based on the use of the EDA domain of fibronectin |
| 02/05/2013 | USRE43982 IGF-1 to improve neural outcome |
| 02/05/2013 | US8367804 High affinity NY-ESO T cell receptors |
| 02/05/2013 | US8367802 Method to produce fibrin monomer in acid media for use as tissue sealant |
| 02/05/2013 | US8367801 Proteinaceous compounds |
| 02/05/2013 | US8367800 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 02/05/2013 | US8367710 Bicyclo-substituted pyrazolon azo derivatives, preparation process and pharmaceutical use thereof |
| 02/05/2013 | US8367673 Substituted diketopiperazines as oxytocin antagonists |
| 02/05/2013 | US8367639 Hydrogels with covalent and noncovalent crosslinks |
| 02/05/2013 | US8367631 Pharmaceutical composition which improves in vivo gene transfer |
| 02/05/2013 | US8367621 Methods and compositions related to internalizing RGD peptides |
| 02/05/2013 | US8367619 Methods for promoting elastogenesis and elastin fiber formation by increasing tropoelastin expression |
| 02/05/2013 | US8367618 Cyclosporin analogues for preventing or treating hepatitis C infection |
| 02/05/2013 | US8367617 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 02/05/2013 | US8367616 Use of a granulin or a granulin-like compound in the therapy or prophylaxis of chronic pains |
| 02/05/2013 | US8367615 Stimulation of neuron regeneration by secretory leukocyte protease inhibitor |
| 02/05/2013 | US8367614 Rheumatoid arthritis-preventive agent for oral intake |
| 02/05/2013 | US8367613 Resuscitation fluid |
| 02/05/2013 | US8367612 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 02/05/2013 | US8367611 Activin-actriia antagonists for inhibiting germ cell maturation |
| 02/05/2013 | US8367610 Method of treating cravings by administration of nerve growth factor |
| 02/05/2013 | US8367609 Methods of reducing skin damage and edema |
| 02/05/2013 | US8367608 Method for promoting secretion of glucagon-like peptide-1 by administering κ-casein |
| 02/05/2013 | US8367607 Oxyntomodulin peptide analogue |
| 02/05/2013 | US8367605 Copolymer-1 improvements in compositions of copolymers |
| 02/05/2013 | US8367604 Fermented milk or vegetable proteins comprising receptor ligand and uses thereof |
| 02/05/2013 | US8367602 Consensus peptides and a method for inducing biomineralization |
| 02/05/2013 | US8367388 Cross-linked compositions |
| 02/05/2013 | US8367374 Nucleotide sequences coding golgi transport protein fusion comprised of N-acetylglucosaminyltransferase III or galactosyltransferase activities for use in generating immunoglobulns for use in treatment of cell proliferative and apototic disorders; immunotherapy |
| 02/05/2013 | US8367097 Liquid formulations for treatment of diseases or conditions |
| 02/05/2013 | US8367070 Modified surface antigen |
| 02/05/2013 | US8367069 Cytotoxic T cell defined EGFR peptide and an optimized derivative peptide |
| 02/05/2013 | US8367066 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 02/05/2013 | US8367062 Glycopeptides derived from pancreatic structures, antibodies and applications thereof in diagnostics and therapeutics |
| 02/05/2013 | US8367060 Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 02/05/2013 | US8367054 Formulations of PEG-interferon alpha conjugates |
| 02/05/2013 | US8367053 Cyclosporin analogues |
| 02/05/2013 | US8367052 Methods for promoting protection and regeneration of bone marrow using CXCL9 and anti-CXCL9 antibodies |
| 02/05/2013 | US8366770 Biological artificial nerve guide and method of making |
| 02/05/2013 | CA2784463A1 Methods for treating myelodysplastic syndrome with ezatiostat |
| 02/05/2013 | CA2672551C Biodegradable block copolymeric compositions for drug delivery |
| 02/05/2013 | CA2651597C Detection of inflammatory disease and composition for prevention or treatment of inflammatory disease |
| 02/05/2013 | CA2558738C Conjugates of hydroxyalkyl starch and a protein, prepared by reductive amination |
| 02/05/2013 | CA2526099C Freeze-dried fsh / lh formulations |
| 02/05/2013 | CA2520023C Stem cells having increased sensitivity to sdf-1 and methods of generating and using same |
| 02/05/2013 | CA2518903C Liquid pharmaceutical formulations of fsh and lh together with a non-ionic surfactant |
| 02/05/2013 | CA2515975C Peptide derivatives having .beta.-secretase inhibitory activity |
| 02/05/2013 | CA2489174C Rna-interference by single-stranded rna molecules |
| 02/05/2013 | CA2468935C Adjuvanted antigenic meningococcal compositions |
| 02/05/2013 | CA2464277C Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 02/05/2013 | CA2428176C Use of the long pentraxin ptx3 for the treatment of diseases caused by an altered activation of the growth factor fgf-2 |
| 02/05/2013 | CA2420867C Methods for enhancing the efficacy of cancer therapy |
| 02/05/2013 | CA2340091C Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/05/2013 | CA2320359C Proteins encoded by polynucleic acids of porcine reproductive and respiratory syndrome virus (prrsv) |
| 02/05/2013 | CA2301199C A tumor suppressor designated ts10q23.3 |
| 01/31/2013 | WO2013016662A1 Diagnosis and treatment of parkinson's disease |
| 01/31/2013 | WO2013016598A2 Methods for reducing reperfusion injury using a hemoglobin-based carbon monoxide carrier |
| 01/31/2013 | WO2013016578A2 Controlled release of ocular biopharmaceuticals using bioresponsive protein polymers |
| 01/31/2013 | WO2013016465A1 Target of the phosphoinositide 3-kinase pathway |
| 01/31/2013 | WO2013016454A1 Assays to monitor bleeding disorders |
| 01/31/2013 | WO2013016427A1 Methods and pharmaceutical compositions for treating celiac disease and gluten intolerance |
| 01/31/2013 | WO2013016297A2 Tumor selective chemokine modulation |
| 01/31/2013 | WO2013016278A2 Modulators of antiviral signaling pathways and therapeutic uses thereof |